• Investing Ideas
  • /
  • German Pharmaceuticals & Biotech Potentially Undervalued Companies
440 companies
CompanyLast Price7D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

6XC

Soleno Therapeutics
US$39.601.0%1,785.7%US$1.4bUS$59.45PB8.8xE60.3%n/a

SZD

Santen Pharmaceutical
JP¥9.105.8%17.4%JP¥547.3bJP¥10.67PE19.7xE7.1%2.1%

2B4

Bonesupport Holding
kr19.502.9%177.4%kr14.7bkr23.61PE60xE14.0%n/a

DPM

Sumitomo Pharma
JP¥2.400.8%-57.1%JP¥160.1bJP¥2.41PB0.5xE70.3%0%

3G0

Altimmune
US$8.28-1.8%108.5%US$628.3mUS$20.26PS1474.9xE-10.8%n/a

VT6

Voyager Therapeutics
US$9.050%36.8%US$519.1mUS$16.83PE3.9xE-40.3%n/a

OXOA

Oxford Biomedica
UK£2.160.9%-55.4%UK£197.1mUK£4.55PS1.7xE52.4%n/a

LC8A

Calliditas Therapeutics
kr19.70-1.5%-6.2%kr6.2bkr35.69PS5.1xE47.6%n/a
Page 19 of 19
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.